Masako Morishita Selected Research

Masako Morishita Research Topics

11	Inflammation (Inflammations) 01/2022 - 08/2004
7	Asthma (Bronchial Asthma) 01/2020 - 04/2002
4	Insulin Resistance 10/2014 - 03/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2013
2	Diabetes Mellitus 05/2014 - 03/2013
1	Neuroinflammatory Diseases 01/2022
1	Lung Injury 01/2021
1	Osteoporosis 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Wounds and Injuries (Trauma) 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Hypertrophy 06/2015
1	Type 2 Diabetes Mellitus (MODY) 10/2014
1	Hyperglycemia 10/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Metabolic Diseases (Metabolic Disease) 08/2013
1	Metaplasia 08/2004
1	Chronic Bronchitis 08/2004
1	Atherosclerosis 06/2004

13	Particulate MatterIBA 01/2022 - 04/2002
5	Air Pollutants (Pollutants, Air)IBA 01/2018 - 04/2002
3	Glucose (Dextrose)FDA LinkGeneric 10/2014 - 01/2014
2	Messenger RNA (mRNA)IBA 06/2015 - 10/2014
2	CytokinesIBA 06/2015 - 11/2009
2	Insulin (Novolin)FDA Link 05/2014 - 01/2014
2	OzoneIBA 01/2014 - 08/2013
2	AllergensIBA 11/2009 - 03/2009
2	OvalbuminIBA 09/2004 - 08/2004
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 01/2022
1	VanadiumIBA 01/2021
1	UraniumIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	HDL LipoproteinsIBA 01/2018
1	SilverIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 10/2014
1	Infliximab (Remicade)FDA Link 10/2014
1	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 10/2014
1	LeptinIBA 05/2014
1	AdiponectinIBA 05/2014
1	CCR2 ReceptorsIBA 01/2014
1	LipidsIBA 01/2014
1	Guanfacine (Tenex)FDA LinkGeneric 01/2014
1	FructoseIBA 08/2013
1	erucylphosphocholineIBA 08/2013
1	Coal (Coals)IBA 11/2009
1	Proteins (Proteins, Gene)FDA Link 11/2009
1	MucinsIBA 11/2009
1	Complex MixturesIBA 07/2005
1	Trace Elements (Biometals)IBA 07/2005
1	Environmental Pollutants (Pollutants, Environmental)IBA 08/2004
1	Phenobarbital (Luminal)FDA Link 08/2004
1	EndotoxinsIBA 08/2004
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 06/2004

1	Oral Administration 01/2016